Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017101
University of California Sys Office/Pres, Oakland, CA, United States
Search grants from University of California Sys Office/Pres
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Exploring the structural basis for 24-hour timekeeping in mammals
Brca1 in development and tumorigenesis
Androgen receptor modulation by Smad5 in prostate cancer
Chagas Disease - Characterization of Cardiac Autoantigens
Synthetic Methods - Site Specific/Latent Antitumor Agents
Recently added grants:
Signaling mechanisms and functions related to patho-physiology of vascular, lung and blood systems
Inflammatory and Dysregulated Repair Responses to Inhaled Nicotine
High Efficiency Delivery of Surfactant Aerosols to Infants without Intubation
The effect of Inhaled Nicotine on Pulmonary Surfaces
Role of endothelial Twist1 in vascular remodeling in pulmonary hypertension
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017101-005
Application #
6828833
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of California Sys Office/Pres
Department
Type
DUNS #
003985512
City
Oakland
State
CA
Country
United States
Zip Code
94607
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017101
/ University of California Sys Office/Pres
Comments
Be the first to comment on this grant